Amoxicillin

Amoxicillin (CAS 26787-78-0) is a broad-spectrum beta-lactam antibiotic supplied as an active pharmaceutical ingredient for human and veterinary drug manufacturing. It targets a wide range of gram-positive and gram-negative bacterial pathogens.

This material is one of the highest-volume antibiotic APIs in global procurement. Wymox is among the recognized brand formulations built on this API for various clinical applications and therapeutic uses.

In human pharmaceutical manufacturing, it is the primary API in oral solid dosage forms such as capsules, tablets, and pediatric suspensions. These are produced at commercial scale worldwide for healthcare providers.

Veterinary drug manufacturers use it to produce injectable and oral formulations under brands such as Vetremox. These products target livestock and companion animal indications across the global agricultural sector.

It is also combined with beta-lactamase inhibitors such as clavulanic acid to produce co-formulated antibiotic products. These address resistant bacterial strains in both human and animal health markets.

Contract manufacturers and generic drug producers source it as a starting material for finished dose production. All manufacturing is conducted under strict GMP-controlled conditions to ensure high purity levels.

The product is supplied as a white to off-white crystalline powder in both trihydrate and anhydrous forms. Standard specifications include USP, BP, and Ph. Eur. to support regulatory submissions.

Bulk quantities are available for industrial API procurement with micronized grades offered for specific formulation requirements. This ensures compatibility with various manufacturing processes and delivery systems.